Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Novartis India Limited
  6. News
  7. Summary
    500672   INE234A01025

NOVARTIS INDIA LIMITED

(500672)
  Report
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Novartis India : launches Biome India, a digital innovation hub in Hyderabad first in Asia

02/25/2020 | 10:42am EST

Novartis announced the launch of the Novartis Biome India, a digital innovation hub aimed at boosting the connection and interaction between Novartis and partners from across the digital ecosystem, from nimble startups and academia to the biggest players in the industry.

The first in Asia, the Novartis Biome India will act as a bridge to the external ecosystem, enabling Novartis teams to better discover, develop and drive collaborations that transform innovative initiatives into impactful and scalable solutions for patients.

By joining this global network, the Novartis Biome India can tap into the assets and expertise of the broader Novartis portfolio to have even greater impact, including: access to anonymized data, customized residency programs, personalized mentoring

'India has a rich and vibrant technology community. Together, we have a fantastic opportunity to combine our scientific know-how with the expertise of tech players, big and small, to create digital solutions for patients, at scale,' Bertrand Bodson, Chief Digital Officer, Novartis. 'Partnerships are at the core of this effort. The Biome's suite of end-to-end services will ensure we deliver on our commitment to both our internal teams and our collaboration partners.'

'We are proud to have the first Novartis Biome in Asia being launched in India. It is testimony to our technology ecosystem. Our ambition is to use data and digital to improve and extend people's lives. We look forward to seeing the outcome of this initiative in the near future,' Sanjay Murdeshwar, Country President, Novartis India.

'We are pleased to have Biome India in Hyderabad and want to leverage this ecosystem to work with startups and innovators to disrupt healthcare in the country and perhaps the world. We will work closely with internal and external partners in pursuit of high value, potentially disruptive innovations,' said Naveen Gullapalli, Head Novartis Hyderabad

About Novartis

Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 109,000 people of more than 145 nationalities work at Novartis around the world.

About Novartis India

Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines company with a strong India footprint, we work to develop and market transformative treatments for people in areas of great medical need. About 8,000 people work at Novartis offices around the country.

Contact:

Svetlana Pinto

Tel: +91 98210 54884

Email: svetlana.pinto@novartis.com

(C) 2020 Electronic News Publishing, source ENP Newswire

Stocks mentioned in the article
ChangeLast1st jan.
NOVARTIS AG -0.59% 79.37 Delayed Quote.-0.51%
NOVARTIS INDIA LIMITED -1.13% 763.45 End-of-day quote.-1.53%
All news about NOVARTIS INDIA LIMITED
2021Novartis India CFO Resigns
MT
2021Novartis India Limited Announces the Resignation of Felix Doss as Chief Financial Offic..
CI
2021Novartis India Limited Reports Earnings Results for the Second Quarter and Six Months E..
CI
2021Trivikram Guda Tenders Resignation from Novartis India Limited as Company Secretary, Ef..
CI
2021NOVARTIS INDIA LIMITED : Ex-dividend day for final dividend
FA
2021NOVARTIS INDIA : Net Profit Climbs in Fiscal Q1
MT
2021Indian Indices End at Mixed Note on Wednesday; Tata Steel Jumps 4%
MT
2021Novartis India Limited Announces Earnings Results for the First Quarter Ended June 30, ..
CI
2021NOVARTIS INDIA : Consolidated Net Profit Climbs in Fiscal Q4
MT
2021Novartis India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, ..
CI
More news
Financials
Sales 2021 3 814 M 51,1 M 51,1 M
Net income 2021 209 M 2,80 M 2,80 M
Net cash 2021 4 349 M 58,3 M 58,3 M
P/E ratio 2021 65,2x
Yield 2021 1,81%
Capitalization 18 850 M 254 M 253 M
EV / Sales 2020 1,66x
EV / Sales 2021 2,43x
Nbr of Employees 539
Free-Float -
Chart NOVARTIS INDIA LIMITED
Duration : Period :
Novartis India Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVARTIS INDIA LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Managers and Directors
Sanjay Prabhakar Murdeshwar Vice Chairman & Managing Director
Christopher Snook Non-Executive Chairman
Jai Vishwanath Hiremath Independent Non-Executive Director
Sandra Martyers Independent Non-Executive Director
Sanker Parameswaran Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
NOVARTIS INDIA LIMITED-1.53%254
JOHNSON & JOHNSON-3.62%434 036
ROCHE HOLDING AG-4.87%319 830
PFIZER, INC.-10.60%296 303
ABBVIE INC.-2.53%233 325
ELI LILLY AND COMPANY-12.00%220 356